Sprucegrove Investment Management LTD Johnson & Johnson Transaction History

Sprucegrove Investment Management LTD

$1.47 Billion
Q3 2024

A detailed history of Sprucegrove Investment Management LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Sprucegrove Investment Management LTD holds 109,135 shares of JNJ stock, worth $15.8 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

109,135

Previous 109,535 0.37%

Holding current value

$15.8 Million

Previous $16 Million 10.48%

% of portfolio

1.2%

Previous 1.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$145.48 - $167.38 $58,191 - $66,952	-400 Reduced 0.37%	109,135 $17.7 Million
Q2 2024 Aug 12, 2024	BUY	$144.38 - $157.78 $187,694 - $205,114	1,300 Added 1.2%	109,535 $16 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $8.34 Million - $8.74 Million	53,700 Added 98.47%	108,235 $17.1 Million
Q4 2023 Jan 29, 2024	BUY	$145.6 - $158.88 $189,280 - $206,544	1,300 Added 2.44%	54,535 $8.55 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $57,471 - $64,383	-369 Reduced 0.69%	53,235 $8.29 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $1.19 Million - $1.28 Million	-7,696 Reduced 12.55%	53,604 $8.87 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $151,050 - $180,260	-1,000 Reduced 1.61%	61,300 $9.5 Million
Q4 2022 Feb 08, 2023	SELL	$160.2 - $179.79 $1.83 Million - $2.05 Million	-11,400 Reduced 15.47%	62,300 $11 Million
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $5.31 Million - $5.91 Million	-32,900 Reduced 30.86%	73,700 $12 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $10.2 Million - $11.3 Million	-60,800 Reduced 36.32%	106,600 $18.9 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $14.6 Million - $16.5 Million	-92,100 Reduced 35.49%	167,400 $29.7 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $3.85 Million - $4.27 Million	-24,700 Reduced 8.69%	259,500 $44.4 Million
Q3 2021 Nov 08, 2021	BUY	$161.5 - $179.47 $2.18 Million - $2.42 Million	13,500 Added 4.99%	284,200 $45.9 Million
Q2 2021 Aug 10, 2021	SELL	$159.48 - $171.07 $303,012 - $325,033	-1,900 Reduced 0.7%	270,700 $44.6 Million
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $520,438 - $579,632	3,400 Added 1.26%	272,600 $44.8 Million
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $20.6 Million - $23.7 Million	150,500 Added 126.79%	269,200 $42.4 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $4.67 Million - $5.12 Million	33,300 Added 38.99%	118,700 $17.7 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $4.64 Million - $5.6 Million	-36,000 Reduced 29.65%	85,400 $12 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $422,332 - $585,162	3,800 Added 3.23%	121,400 $15.9 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $171,615 - $197,108	1,346 Added 1.16%	117,600 $17.2 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $311,535 - $348,811	2,454 Added 2.16%	116,254 $15 Million
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $1.63 Million - $1.79 Million	-12,400 Reduced 9.83%	113,800 $15.9 Million
Q1 2019 May 07, 2019	SELL	$125.72 - $139.79 $4.15 Million - $4.61 Million	-33,000 Reduced 20.73%	126,200 $17.6 Million
Q4 2018 Feb 08, 2019	SELL	$122.84 - $147.84 $1.74 Million - $2.1 Million	-14,200 Reduced 8.19%	159,200 $20.5 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $389,056 - $457,216	3,200 Added 1.88%	173,400 $24 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $1.21 Million - $1.33 Million	-10,100 Reduced 5.6%	170,200 $20.7 Million
Q1 2018 May 11, 2018	SELL	$125.1 - $148.14 $250,200 - $296,280	-2,000 Reduced 1.1%	180,300 $23.1 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $5.2 Million - $5.69 Million	-39,600 Reduced 17.85%	182,300 $25.5 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $28.7 Million - $30 Million	221,900	221,900 $28.8 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sprucegrove Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sprucegrove Investment Management LTD with notifications on news.

Account

Sprucegrove Investment Management LTD Johnson & Johnson Transaction History